FEVARIN

This brand name is authorized in Croatia, Estonia, Germany, Italy, Lithuania, Netherlands, Poland, Romania.

Active ingredients

The drug FEVARIN contains one active pharmaceutical ingredient (API):

1	Fluvoxamine UNII 5LGN83G74V - FLUVOXAMINE MALEATE
	The mechanism of action of fluvoxamine is thought to be related to selective serotonin re-uptake inhibition in brain neurones. There is minimum interference with noradrenergic processes. Receptor binding studies have demonstrated that fluvoxamine has negligible binding capacity to alpha adrenergic, beta adrenergic, histaminergic, muscarine cholinergic, dopaminergic or serotonergic receptors.
	Read more about Fluvoxamine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AB08	Fluvoxamine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02796575, 02796581, 02796598, 03655049, 03655055, 07669634
EE	Ravimiamet	1039564, 1070569, 1070570, 1115503, 1149791, 1149803
HR	Agencija za lijekove i medicinske proizvode	HR-H-748870845
IT	Agenzia del Farmaco	027045032, 027045044
LT	Valstybinė vaistų kontrolės tarnyba	1000762, 1000763, 1000764, 1086868, 1087896, 1090872, 1091526
NL	Z-Index G-Standaard, PRK	42013, 42021
PL	Rejestru Produktów Leczniczych	100024196, 100024204, 100436510, 100436527, 100453071
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68887001, W68888001